RT-PCR studies on human dendritic cells shows our technology downregulates genes that shut down the immune system.
Copyright © Immudicon LLC. All rights reserved.
Recognized by CNN, American Association for Cancer Research, Google X, the Milken Institute, TEDxJohnson&
MacroVax our lead technology hinges on specific lectins to induce a tumor-specific immune response.